Company NurExone Biologic Inc. Toronto S.E.

Equities

ENER

CA29278Q1063

Biotechnology & Medical Research

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Other Biotechnology & Medical Research

Inactive Instrument

NurExone Biologic Inc. is a biopharmaceutical company. The Company is developing and commercializing an exosome therapy ExoTherapy production platform and products for a global market. It is involved in the development of ExoPTEN, the first ExoTherapy-based product for acute Spinal Cord Injuries (SCI). The Company is developing treatment for the reversal or reduction of paralysis following spinal cord injury (SCI) using Exosomes (membrane-bound extracellular vesicles). This technology, subject to conducting clinical trials and receiving Food and Drug Administration (the FDA) approval, can be used in various conditions such as SCI, Brain Trauma Injury (BTI), and potentially other brain and neurological indications.

Managers	Title	Age	Since
Lior Shaltiel CEO	Chief Executive Officer	-	21-03-31
Eran Ovadya DFI	Director of Finance/CFO	-	22-06-14

Members of the board	Title	Age	Since
Jay Richardson BRD	Director/Board Member	78	22-01-02
Gadi Riesenfeld BRD	Director/Board Member	79	23-07-05
Yoram Drucker CHM	Chairman	59	19-12-31
Oded Orgil BRD	Director/Board Member	57	22-06-14
Lior Shaltiel CEO	Chief Executive Officer	-	21-03-31

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	65,814,822	61,834,822 ( 93.95 %)	0	93.95 %

Name	Equities	%	Valuation
Yoram Drucker 5.836 %	3,230,000	5.836 %	2 M $
Ron Abraham Mayron 1.229 %	680,000	1.229 %	376 040 $
Jay Richardson 0.1265 %	70,000	0.1265 %	38 710 $
Gadi Riesenfeld 0.000000 %	0	0.000000 %	- $
Oded Orgil 0.000000 %	0	0.000000 %	- $
Lior Shaltiel 0.000000 %	0	0.000000 %	- $
Eran Ovadya 0.000000 %	0	0.000000 %	- $

NurExone Biologic, Inc.

9 Mezada Street BSR 3 Tower

5120109, Bnei-Brak

http://www.nurexone.com

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
IQVIA HOLDINGS INC.	+0.67%	42.19B
LONZA GROUP AG	+44.30%	40.15B
CELLTRION, INC.	-6.20%	28.31B
ICON PUBLIC LIMITED COMPANY	+6.55%	24.63B
ALNYLAM PHARMACEUTICALS, INC.	-21.66%	18.2B
MEDPACE HOLDINGS, INC.	+29.96%	12.01B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.57%	11.76B
UNITED THERAPEUTICS CORPORATION	+16.03%	10.4B
BIO-TECHNE CORPORATION	-4.80%	9.94B

Other Biotechnology & Medical Research